NUVISAN The Science CRO
Peter Huber began their work experience in 1992 as a Trainee Lab Technican at Grünau Illertissen GmbH. Peter worked there until 1995. In 2000, they joined Nuvisan Pharma Services Group as an Analyst Bioanalytics LCMS and held that position until 2010. From 2010 to 2017, they worked at Nuvisan Pharma Services Group as a Project Manager Bioanalytic. Since March 2017, they have been serving as the Head Method Development and Validation LCMS Bioanalysis at the same company.
Peter Huber attended FH Isny from 1996 to 2000, where they obtained a degree in Chemie with the title of Dipl. Ing. (FH). Later, from 2006 to 2008, they attended Hochschule Neu-Ulm to pursue their MBA degree with a concentration in BWL.
NUVISAN The Science CRO
1 followers
Founded in Europe with more than 40 years of experience, NUVISAN is a fully integrated contract research and development, and manufacturing organization (CRO/CDMO) that offers unique, high-quality, and tailored integrated solutions along the drug discovery and development value chain. With more than 1.000 employees distributed over six locations in Germany and France including our drug discovery hub in Berlin as well as with local experts situated in Latin America, NUVISAN is pleased to offer the following portfolio of services: • Drug discovery & research - Discovery pharmacology - Discovery bioscience - Screening - Life science chemistry - Translation research - Digital life science - Toxicology - DMPK • Non-clinical studies • Pharmaceutical analysis • Topical formulation development • Chemical development with GMP manufacturing (3-10kg) • Bioanalytical labs • GMP manufacturing (up to 50Kg) • Clinical trial supplies • Phase 1 and 2 clinical studies and beyond Our services can be provided as stand-alone or integrated solutions and can be customized to your project. Email us at hello@nuvisan.com for more.